COVID-19 Vaccine Development Tools Market (By Technology: Laboratory Technologies, Online Technologies; By Application: Vaccine Research, Vaccine Process Development, Vaccine Quality Assurance/Quality Control; By End-use: Pharma & Biopharma Companies, Contract Research Organization (CROs), Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global COVID-19 Vaccine Development Tools market size is expected to be worth around US$ 40.5 billion by 2030, according to a new report by Vision Research Reports.

The global COVID-19 Vaccine Development Tools market size was valued at US$ 20.01 billion in 2020 and is anticipated to grow at a CAGR of 10.6% during forecast period 2021 to 2030.

Growth Factors

 This is attributed to the persisting devastation of SARS-CoV-2 across the globe. Additionally, second waves of SARS-CoV-2 infection were expected to coincide with the beginning of winter in the northern hemisphere, indicating the crucial period in the pandemic’s timeline.

Thus, the development of a viable immunization shot is imperative to mitigate the global impact of COVID-19. Acknowledging this need, entities engaged in the development of effective inoculation against COVID-19, are aiming at 4 potential key vaccine candidates, namely, mRNA, recombinant, inactivated, and replication-deficient viral vector. These 4 candidates are the key areas of focus, and the integration of and chromatography for candidate characterization is common across the development process of all the above candidates.

Report Highlights

 The vaccine research segment dominated the market and accounted for the largest revenue share of 53.9% in 2020. The growth of the segment is driven by several factors such as rising government funding, extensive research by universities and healthcare organizations, and increasing business development strategies by prominent pharmaceutical companies, among others. Moreover, the growth in the segment can be further attributed to continuous research activities for improving the vaccine development process.

The researchers at Stanford University are working on the development of a single-dose vaccine for coronavirus that could potentially be stored at room temperature. This could possibly help in reducing the cost of storage and transportation associated with vaccines. Moreover, companies are increasingly engaged in business development strategies such as agreements, partnerships, and collaborations for COVID-19 target discoveries.

The pharma and biopharma companies dominated the market and accounted for the largest revenue share of over 52.0% in 2020. These companies were amongst the initial key players in conducting studies on SARS-CoV-2 in the early stages of the pandemic owing to their existing vaccine development infrastructure. For instance, in January 2020, the researchers at Merck Research Labs gathered a previously available understanding of coronavirus and proceeded with the identification of possible approaches for vaccines and therapeutics development with potential activity against SARS-CoV-2. The company examined around 1,000 compounds from its vast libraries for evaluating their activity against SARS-CoV-2.

The large share of the segment can be attributed to the robust investment capabilities of pharmaceutical companies for facilitating the rapid development of the COVID-19 vaccine. Large-scale pharmaceutical companies are collaborating with biotech companies for assisting them in scaling up the manufacturing process of the COVID-19 vaccine.

Asia Pacific dominated the COVID-19 vaccine development tools market and accounted for the largest revenue share of 49.6% in 2020. A major factor that contributed to the accelerated vaccine development for the SARS-CoV-2 was the early identification of the novel coronavirus’ genome by using advanced sequencing techniques in the region. The researchers in China conducted several studies directed at early genome sequencing, viral structure analysis, and immune response profiling with the application of next-generation sequencing, electron microscopy, and flow cytometry, respectively.

Key Players

• Thermo Fisher Scientific, Inc.

• Celerion

• Cole-Parmer Instrument Company, LLC.

• Pfizer Inc.

• Sartorius AG

• STEMCELL Technologies Inc.

• AB Sciex Pte. Ltd.

• Illumina, Inc.

• Agilent Technologies

• Bio-Rad Laboratories, Inc.

• Danaher

• Merck KGaA

• Qiagen N.V.

• Shimadzu Corporation

• Eurofins Scientific

• Charles River Laboratories

• Takara Bio Inc.

• PerkinElmer Inc.

• Fluidigm

• OLYMPUS CORPORATION

• Avantor, Inc.

• Polyplus Transfection

• Hamilton Company

• Aurora Biomed Inc. 

Market Segmentation

• Technology Outlook 

  • Laboratory Technologies

    • Next Generation Sequencing

    • PCR & qPCR

    • Flow Cytometry

    • Spectrometry

    • Microscopy & Electron Microscopy

    • Preparative & Process Chromatography

    • Nucleic Acid Isolation & Purification

    • Transfection Electroporation

    • Cell Culture

    • Automated Liquid Handling

  • Online Technologies

    • Interactive Web Technologies

    • Vaccine Management & Tracker Technologies

• Application Outlook 

  • Vaccine Research

  • Vaccine Process Development

  • Vaccine Quality Assurance/Quality Control

• End-use Outlook

  • Pharma & Biopharma Companies

  • Contract Research Organization (CROs)

  • Academic & Research Institutes

• Regional Outlook

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Italy

    • France

    • Spain

    • Russia

  • Asia Pacific

    • China

    • India

    • South Korea

    • Australia

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

The COVID-19 Vaccine Development Tools market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of COVID-19 Vaccine Development Tools market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global COVID-19 Vaccine Development Tools market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Vaccine Development Tools market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted COVID-19 Vaccine Development Tools market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the COVID-19 Vaccine Development Tools capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of COVID-19 Vaccine Development Tools by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global COVID-19 Vaccine Development Tools market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major COVID-19 Vaccine Development Tools market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of COVID-19 Vaccine Development Tools market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the COVID-19 Vaccine Development Tools industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

COVID-19 Vaccine Development Tools market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 Vaccine Development Tools market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of COVID-19 Vaccine Development Tools market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new COVID-19 Vaccine Development Tools market. These factors have benefited the growth of the global market for COVID-19 Vaccine Development Tools. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for COVID-19 Vaccine Development Tools. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of COVID-19 Vaccine Development Tools are as follows:

• History Year: 2017-2020

• Base Year: 2021

• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.